[Federal Register Volume 64, Number 38 (Friday, February 26, 1999)]
[Notices]
[Page 9541]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-4754]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on November 23, 1998, Medeva 
Pharmaceuticals CA, Inc., 3501 West Garry Avenue, Santa Ana, California 
92704, made application by renewal to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of the 
basic classes of controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Methylphenidate (1724).....................  II
Diphenoxylate (9170).......................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances to 
make finished dosage forms for distributions to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than April 27, 1999.

    Dated: February 5, 1999.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 99-4754 Filed 2-25-99; 8:45 am]
BILLING CODE 4410-09-M